Related Articles
Alteration of the serum myostatin level following L‑carnitine treatment in patients with chronic liver disease: A pilot study
Effect of levocarnitine administration in patients with chronic liver disease
Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.
Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenib
Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats